You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1851 to 1875 of about 5939
Next 25
09/20/2015
Caffeine inhibits the growth of glioblastomas through activating the caspase-3 signaling pathway in vitro.
09/12/2015
Novocure to Present the Latest Data from the EF-14 Clinical Trial in Newly Diagnosed GBM at the 15th Interim Meeting of the World Federation of Neurosurgical Societies
Life After Brain Cancer Diagnosis: Max`s Story
09/08/2015
Novocure Announces Optune® Now Available at more than 200 Leading Cancer Centers across the United States
09/04/2015
Voices Against Brain Cancer is now accepting Brain Tumor Research Grant Requests
09/01/2015
UCLA Researchers Develop a Likely New Combo Treatment for the Deadliest Form of Brain Cancer
Oncoceutics Awarded Grant for Phase II Brain Cancer Trial
08/31/2015
IBTA Newsletter
08/29/2015
Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
08/26/2015
WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials
Enrollment Begins In Expansion Phase of ONC201 Clinical Trial
Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.
08/25/2015
FDA Grants Orphan Drug Designation for Tocagen`s Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma
08/24/2015
?Celldex and the limits of ‘overall survival benefit’ in cancer trials
Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child-Resistant Closure Requirement
NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing Patients In Trial Continuing To Be Treated Per Protocol, Including In Germany
Update posted for Ben Williams` "Treatment Options for Glioblastoma and other Gliomas"
08/17/2015
San Diego couple trying to stop time with Novocure
Added survivor story Debbie - 10 year GBM survivor!
08/14/2015
Cleveland Clinic researcher awarded National Cancer Institute`s Outstanding Investigator Award
ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma
08/12/2015
Can a Lung Cancer Drug Fight Brain Tumors?
08/09/2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
08/05/2015
Colchicine derivative as a potential anti-glioma compound.
Musella Foundation Copayment Assistance Program is now closed to new patients